Hudson Bay Capital Management LP Bio Rad Laboratories, Inc. Transaction History

Hudson Bay Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $7.66 Million - $9.65 Million	-15,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$454.43 - $535.6 $6.82 Million - $8.03 Million	15,000 New	15,000 $7.73 Million
Q4 2019 Feb 12, 2020	SELL	$319.73 - $374.2 $11.1 Million - $13 Million	-34,625 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$304.55 - $345.24 $10.2 Million - $11.5 Million	-33,375 Reduced 49.08%	34,625 $11.5 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $7.98 Million - $8.7 Million	27,822 Added 69.25%	68,000 $21.3 Million
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $3.36 Million - $4.76 Million	14,998 Added 59.56%	40,178 $12.3 Million
Q4 2018 Feb 13, 2019	BUY	$220.1 - $309.0 $560,374 - $786,714	2,546 Added 11.25%	25,180 $5.85 Million
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $5.82 Million - $6.57 Million	-20,134 Reduced 47.08%	22,634 $7.08 Million
Q2 2018 Aug 13, 2018	SELL	$244.1 - $303.88 $6.77 Million - $8.43 Million	-27,726 Reduced 39.33%	42,768 $12.3 Million
Q1 2018 May 14, 2018	BUY	$233.97 - $274.11 $16.5 Million - $19.3 Million	70,494 New	70,494 $17.6 Million

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.48B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.